نتائج البحث 451-460 من 13936 لعملية البحث عن alzheimers
Biology-based criteria for diagnosis, staging of Alzheimer's disease · Mayo Clinic Q and A: My mom has Alzheimer's. What does that mean for me? Minnesota ...
Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...
... Alzheimer's disease. EF-41/KEYNOTE D58: Phase 3 Study Of Optune Concomitant With Temozolomide Plus Pembrolizumab In Newly Diagnosed Glioblastoma.
Meredith R. Wicklund, M.D.. Neurologist. Phoenix, AZ. مناطق التركيز: Mild cognitive impairment, Dementia, Alzheimer's disease, Frontotemporal dementia, ...
Jonathan Graff-Radford, M.D.. Neurologist. Rochester, MN. مناطق التركيز: Transient ischemic attack, Stroke, Dementia, Cerebral amyloid angiopathy, Alzheimer's ...
This may help medicines reach the brain to treat conditions such as Alzheimer's disease. ... Safety, efficacy and clinical applications of focused ultrasound- ...
Dominantly Inherited Alzheimer Network (DIAN) ... The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's ...
Alzheimer's Association. https://www.alz.org/alzheimers-dementia/what-is-dementia. Accessed April 24, 2023. Dementias. https://www.ninds.nih.gov/Disorders ...
A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease. Scottsdale ...
... Alzheimer's Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.